Skip to main content
Premium Trial:

Request an Annual Quote

LunaPBC Nabs $4.6M in Funding

NEW YORK (GenomeWeb) – LunaPBC has announced $4.6 million in new funding.

The La Jolla, California-based firm said the funds will be used to accelerate research partnerships; bring on new partners, including Genetic Alliance; and expand marketing and development of its LunaDNA genomic and health data sharing platform.

The round was led by Arch Venture Partners, Bain Capital Ventures, F-Prime Capital, Illumina Ventures, and Osage University Partners.

"It's the right time to reimagine the role and rights of individuals across the globe in driving health discovery with their life data," Yumin Choi, partner at Bain Capital Ventures, said in a statement. "We are excited about LunaPBC's people-first model, which empowers individuals as valued partners, not just research subjects; will create a deeper dataset with environment-specific and people-reported data; and has an intentional public benefit component to ensure long-standing impact in our communities."

LunaPBC said it has raised $7.6 million to date. In December 2017, the firm raised $2 million in seed funding.

CEO and co-founder Bob Kain also announced new corporate advisors: Jason Paragas of Integral Health; Doug Harrison, founder of Harrison Group; and Chris Cabou, formerly general counsel at Illumina.

The Scan

Call for a Different Tack

Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News.

Wastewater Warning

The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge.

Can't Get in the Program

Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports.

Science Paper on Spatial-Controlled Genome Editing

In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.